Cancer Patients Follow-Up – Croatian Society of Medical Oncology Clinical Guidelines Part Iii: Neuroendocrine Neoplasms, Hepatocellular Carcinoma, Pancreatic Cancer, Cancer of the Bile Ducts
Plavetić, N.Dedić.; Dražin, R.Kelemenić.; Dintinjana, R.Dobrila.; Radić, M.; Prejac, J.; Dolić, Z.Mišetić.; Pavlović, M.; Škegro, M.; Šeparović, R.; Vrbanec, D.
Lijecnicki vjesnik 138(7-8): 173-178
2016
ISSN/ISBN: 0024-3477 PMID: 30091882 Document Number: 690362
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow-up of oncological patients after primary treatment, in patients with neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer and cancer of the bile ducts.